Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Stephen Furlong, the Executive Vice President, Chief Financial Officer, and Treasurer of Neuronetics , Inc. (NASDAQ:STIM), recently sold shares of the company’s common stock. According to a filing with the Securities and Exchange Commission, Furlong sold 17,307 shares on February 14, 2025, at a weighted average price of $4.11 per share. The total value of the transaction amounted to $71,131.
The transaction was part of a non-discretionary sale to satisfy Furlong’s tax withholding obligations upon the vesting of a portion of a restricted stock unit award. Following this sale, Furlong retains ownership of 454,420 shares of Neuronetics.
Neuronetics, a company based in Malvern, Pennsylvania, specializes in surgical and medical instruments and apparatus. The stock is currently trading near its 52-week high of $5.07, reflecting strong market momentum.
In other recent news, Neuronetics, a global leader in neuroscience, has announced a public offering of its common stock, with Canaccord Genuity LLC serving as the sole bookrunner. The sale is subject to a shelf registration statement filed with the U.S. Securities and Exchange Commission and is contingent upon market and other conditions. In parallel, Neuronetics has revealed its preliminary unaudited revenue for the fourth quarter and full year of 2024, posting revenues of $22.1 million and $74.5 million respectively. Following its recent acquisition of Greenbrook TMS, a network of mental health treatment clinics, the company’s pro forma consolidated revenue for 2024 stands at $34.7 million for the fourth quarter and $129.8 million for the full year. Neuronetics expects a revenue range of $145.0 million to $155.0 million for fiscal year 2025, representing a 12% to 19% increase on a pro forma basis. Additionally, the company projects to achieve cash flow breakeven in the third quarter of 2025. These recent developments reflect the company’s ongoing activities and future expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.